Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
Eli Lilly(LLY) stock is priced at $1,180.00, giving the company a market capitalization of 1.11T. It carries a P/E multiple of 41.47 and pays a dividend yield of 0.53%.
On 2026-08-15, Eli Lilly(LLY) stock traded between a low of $1,171.20 and a high of $1,207.80. Shares are currently priced at $1,180.00, which is +0.8% above the low and -2.3% below the high.
The Eli Lilly(LLY)'s current trading volume is 2.27M, compared to an average daily volume of 3.11M.
During the past year, Eli Lilly(LLY) stock moved between $685.15 at its lowest and $1,249.45 at its peak.
During the past year, Eli Lilly(LLY) stock moved between $685.15 at its lowest and $1,249.45 at its peak.
LLY News
Key Points Amgen is developing a highly differentiated GLP-1 product. Regeneron has a pair of promising GLP-1 candidates in the pipeline. Both biotechs are p...
...
Glenview Capital Management took new equity positions in Eli Lilly (LLY), with nearly 58K shares, and AbbVie (ABBV), with ~149K shares, according to the hedge f...
Analyst ratings
81%
of 32 ratingsMore LLY News
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more co...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more co...
Eli Lilly (NYSE: LLY) has launched a legal crackdown on illicit U.S. sales of its experimental obesity drug retatrutide, which is not approved for any use. The...
IBD Big Cap 20 Eli Lilly Stock Nears Buy Point After Earnings-Fueled Gains Licensing Eli Lilly (LLY) is the Big Cap 20 component in focus this week, as the stoc...
Novo Nordisk (NVO -0.91%) posted strong first-quarter results and performed fairly well in the month that followed its first-quarter update. However, the compan...
Novo Nordisk (NVO) CEO Mike Doustdar is defending the European drug maker’s lawsuit against U.S. rival Eli Lilly (LLY) over what it alleges is false advertising...
Shares in Danish drugmaker Novo Nordisk (NVO) fell about 2% to roughly $46 per share early Thursday. The decline came even though CEO Mike Doustar told Reuters...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.